We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Flavonoids Found To Regulate Cell Processes, Enhance Health

By Biotechdaily staff writers
Posted on 05 Nov 2007
For the first time, scientists have proved that plant substances such as those found in red wine, soy, or green tea can accelerate or suppress vital processes in cells. More...
These molecules bind to the protein actin, which is implicated in cell movement and cell division.

According to preclinical findings published in the October 2007 issue of the Biophysical Journal, the ability of actin to join to long chains is either suppressed or improved. Surprisingly, it has been shown that these substances also affect the rate at which genetic data are processed in the cell's nucleus.

A large family of plant pigments, the flavonoids, comprises over 6,000 structurally related substances found in fruit and vegetables of our daily diet. They appear to induce the positive health effects of green tea or red wine. However, their functional mechanisms are diverse and not well understood. This complicates the effective evaluation of their beneficial effects as well as possible health risks. Many scientists try to understand these mechanisms on a molecular level, hoping to learn from nature to design new compounds that can be used in therapies of cancer or heart diseases.

The recent study reports two surprising results that are related to the binding of flavonoids to the protein actin. Actin is one of the most examined and abundant proteins. Together with other biomolecules, it enables muscle contraction, changing the cell shape and separation of daughter cells during cell division. In 2005, biologists from the Technische Universität Dresden (Germany) were surprised to find that flavonoids can bind to actin in the nucleus of living cells.

Now, together with the biophysics group at the Forschungszentrum Dresden-Rossendorf (FZD; Dresden, Germany), the investigators established in the laboratory that flavonoids influence the growth of chains of actin molecules, a process that is linked to the cellular functions of actin. Flavonoids can strengthen or weaken this process. Amazingly, the same dependency on flavonoids was observed for the speed at which the genetic material is read from the DNA in the cell nucleus. These findings, according to Prof. Herwig O. Gutzeit, from the Technische Universität Dresden, demonstrate that the direct biologic effects of flavonoids on actin may also influence the activity of genes in a cell.

Biophysicist Dr. Karim Fahmy, from the Forschungszentrum Dresden-Rossendorf, was able to demonstrate the molecular mechanism by which flavonoids can affect actin functions. The flavonoids function as switches that bind to actin and promote or inhibit its functions. Using infrared spectroscopy, Dr. Fahmy evaluated the interaction of actin with the activating flavonoid epigallocatechin and the inhibitor "quartering.” This method is well suited for demonstrating structural alterations in large biomolecules without any interventions that may affect the extremely sensitive proteins. Upon addition of the selected flavonoids to actin, the structure of the actin changes in a dramatic and typical way. Depending on the type of flavonoid, the "actin switch” is set to increased or reduced functional activity.

The mechanism appears obvious to the scientists: the effects of the flavonoids are a function of their form. Actin itself is a flexible molecule, which clarifies why various flavonoids can bind to actin in a very similar way but nevertheless produce effects that range from inhibition to stimulation. Flexible flavonoids correspond to the structure of the actin and create complexes that improve actin functions.

More rigid flavonoids force the actin into a structure that is less compatible with its natural functions, thereby inhibiting actin-dependent cellular processes. Simulations of flavonoid binding to actin performed in the bioinformatics group of Dr. Apostolakis at the Ludwig-Maximilian University of Munich (Germany) identified the putative site where flavonoids interact with actin. The collaborative and highly interdisciplinary efforts allowed determining previously unknown structure-specific functional processes of flavonoids. This knowledge should help in the near the future in the search for compounds with improved effectiveness and specificity that can be used to modulate actin functions for therapeutic purposes.


Related Links:
Forschungszentrum Dresden-Rossendorf
Technische Universität Dresden

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.